QT
TBPH icon

Quantbot Technologies’s Theravance Biopharma TBPH Stock Holding History

Quantbot Technologies’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Sell
7,269
-12,078
-62% -$214K ﹤0.01% 1291
2025
Q4 		$362K Sell
19,347
-7,167
-27% -$119K 0.01% 1046
2025
Q3 		$387K Buy
+26,514
New +$335K 0.01% 1115
2024
Q4 		– Sell
-7,396
Closed -$59.6K – 1818
2024
Q3 		$59.6K Buy
+7,396
New +$64.1K ﹤0.01% 1262
2023
Q2 		– Sell
-9,988
Closed -$108K – 1950
2023
Q1 		$108K Buy
9,988
+56
+0.6% +$592 0.01% 1065
2022
Q4 		$111K Sell
9,932
-3,968
-29% -$41.7K 0.01% 1097
2022
Q3 		$140K Buy
13,900
+6,995
+101% +$65.5K 0.01% 1003
2022
Q2 		$62K Buy
+6,905
New +$63.6K 0.01% 1254
2020
Q4 		– Sell
-6,700
Closed -$99K – 1667
2020
Q3 		$99K Buy
+6,700
New +$126K 0.01% 727
2020
Q1 		– Sell
-10,141
Closed -$262K – 1365
2019
Q4 		$262K Buy
10,141
+6,991
+222% +$136K 0.03% 590
2019
Q3 		$61K Sell
3,150
-4,450
-59% -$89.9K 0.01% 934
2019
Q2 		$124K Buy
+7,600
New +$154K 0.01% 719
2018
Q2 		– Sell
-411
Closed -$9K – 1481
2018
Q1 		$9K Buy
+411
New +$11.3K ﹤0.01% 1119

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's TBPH Position: Q1 2026 in Review

Quantbot Technologies reduced its Theravance Biopharma (TBPH) stake by 62% in Q1 2026, selling an estimated $214K and leaving 7,269 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Quantbot Technologies first reported a position in TBPH in Q1 2018 and has held it in 13 quarters since. The position peaked at $387K in Q3 2025. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Quantbot Technologies held 7,269 shares of Theravance Biopharma worth $118K as of Q1 2026.
  • Quantbot Technologies sold 12,078 Theravance Biopharma shares in Q1 2026, an estimated $214K.
  • Theravance Biopharma made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1291 holding.
  • Quantbot Technologies first reported a position in Theravance Biopharma in Q1 2018 and has held it in 13 quarters since.
  • Quantbot Technologies's Theravance Biopharma position peaked at $387K in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.